Welcome to LookChem.com Sign In|Join Free
  • or
3-IMINOISOINDOLINONE, an iminoisoindolinone derivative with the molecular formula C8H6N2O, is a chemical compound that has garnered attention in the field of medicinal chemistry. Its unique structure and biological activities have positioned it as a promising candidate for therapeutic applications, particularly in the areas of cancer treatment and inflammation management.

14352-51-3

Post Buying Request

14352-51-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

14352-51-3 Usage

Uses

Used in Pharmaceutical Industry:
3-IMINOISOINDOLINONE is used as an anticancer agent for its ability to inhibit the growth of cancer cells. Its potential therapeutic applications have been extensively studied, making it a valuable compound in the development of novel cancer treatments.
3-IMINOISOINDOLINONE is also used as an anti-inflammatory agent due to its potential to manage inflammation-related conditions. Its pharmacological properties have been investigated for their impact on inflammatory processes, offering a promising avenue for the treatment of various inflammatory diseases.
In Medicinal Chemistry Research:
3-IMINOISOINDOLINONE serves as a subject of interest for researchers in medicinal chemistry. Its intriguing biological activities and potential as a drug candidate for a range of diseases make it a valuable asset in the discovery and development of new therapeutic agents. Ongoing studies aim to further explore its pharmacological properties and optimize its therapeutic potential.

Check Digit Verification of cas no

The CAS Registry Mumber 14352-51-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,3,5 and 2 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 14352-51:
(7*1)+(6*4)+(5*3)+(4*5)+(3*2)+(2*5)+(1*1)=83
83 % 10 = 3
So 14352-51-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H6N2O/c9-7-5-3-1-2-4-6(5)8(11)10-7/h1-4H,(H2,9,10,11)

14352-51-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-aminoisoindol-1-one

1.2 Other means of identification

Product number -
Other names 3-Iminoisoindolin-1-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:14352-51-3 SDS

14352-51-3Relevant academic research and scientific papers

Photolysis of 3-(2-Formylphenyl)-3-chlorodiazirine in an Ar Matrix at Low Temperature

Nakane, Norio,Enyo, Tomonori,Tomioka, Hideo

, p. 3538 - 3545 (2004)

Photolysis of 3-(2-formylphenyl)-3-chlorodiazirine in an Ar matrix at 13 K was monitored by IR and UV-vis spectroscopies. Characterization of the products was carried out by comparing the spectra with the theoretical IR spectra obtained by using DFT, which suggested that anti,anti-2-formylphenyl(chloro)carbenes (a,a-2), ketenes (syn- and anti-3), chlorobenzocyclobutenone (4), and chloroisobenzofurane (5) were formed. This indicates that carbene 2 interacts with both hydrogen and oxygen in the formyl group. When the matrix containing a,a-2 was allowed to stand in the dark at 13 K, a gradual increase of the band due to anti-ketene 3 at the expense of 2 was observed. In contrast to its protio analogue, the deuterated carbene 2-d showed almost no changes either for the decay of 2-d or the growth of 3-d within the time range where the protio analogue appreciably decayed. These observations are interpreted in term of a quantum mechanical tunneling mechanism.

The structures of several modified isoindolines, the building blocks of phthalocyanines

Engle, James T.,Allison, Ashley N.,Standard, Joshua M.,Tamgho, Ingrid-Suzy,Ziegler, Christopher J.

, p. 712 - 721 (2013)

This report presents the single crystal X-ray structures of several substituted isoindolines that have been frequently used as starting materials for phthalocyanines, phthalocyanine analogs and related chelates. The structures of 1,3-diiminoisoindoline (1), 1,3-bis(hydroxyimino)isoindoline (2), 1,4-diaminophthalazine (3), 1,1,3-trichloroisoindoline (4) and 3-imino-1-oxoisoindoline (5) are reported; compounds 2 and 3 are synthesized from diiminoisoindoline (1) and 4 and 5 are produced from phthalimide. All five compounds are planar macrocycles, and localization of double bonds can be readily determined. We elucidated one of the known structures of 1 at low temperature, and observed two additional new structures of 1. For the crystal forms of 1 and compounds 2, 3, and 5, hydrogen bonding in the solid state was observed. Compounds 1, 2 and 3 form extended hydrogen bonded arrays in the solid state, whereas 5 forms discrete hydrogen bonded dimers.

Cyclic acyl amidines as unexpected C4-donors for fully substituted pyridine ring formation in the base mediated reaction with malononitrile

Tkachuk, Volodymyr,Merkulova, Vladyslava,Omelchenko,Arrault, Axelle,Hordiyenko, Olga

, p. 1959 - 1963 (2019)

A new one-step, pseudo four-component approach for the synthesis of fully substituted pyridines via ring-opening of the cyclic acyl amidine of 3-amino-1H-isoindol-1-one and its aza-analogues during the reaction with malononitrile in the presence of sodium methoxide, followed by pyridine ring closure is reported. This method allows the one-step preparation of previously unknown 2-(pyridin-4-yl)(hetero)aryl carboxamides in good yields under mild reaction conditions.

Discovery of a Potent and Orally Bioavailable Hypoxia-Inducible Factor 2α (HIF-2α) Agonist and Its Synergistic Therapy with Prolyl Hydroxylase Inhibitors for the Treatment of Renal Anemia

Yu, Yancheng,Yang, Fulai,Yu, Quanwei,Liu, Simeng,Wu, Chenyang,Su, Kaijun,Yang, Le,Bao, Xiaoqian,Li, Zhihong,Li, Xiang,Zhang, Xiaojin

, p. 17384 - 17402 (2021/11/16)

Activation of hypoxia-inducible factor 2 (HIF-2) has emerged as a potent renal anemia treatment strategy. Here, the benzisothiazole derivative 26 was discovered as a novel HIF-2α agonist, which first demonstrated nanomolar activity (EC50 = 490 nM, Emax = 349.2%) in the luciferase reporter gene assay. Molecular dynamics simulations indicated that 26 could allosterically enhance HIF-2 dimerization. Furthermore, compound 26 had a good pharmacokinetic profile (the oral bioavailability in rats was 41.38%) and an in vivo safety profile (the LD50 in mice was greater than 708 mg·kg-1). In the in vivo efficacy assays, the combination of 26 and the prolyl hydroxylase inhibitor, AKB-6548, was confirmed for the first time to synergistically increase the plasma erythropoietin level in mice (from 260 to 2296 pg·mL-1) and alleviate zebrafish anemia induced by doxorubicin. These results provide new insights for HIF-2α agonists and the treatment of renal anemia.

Insight into the binding mode of HIF-2 agonists through molecular dynamic simulations and biological validation

Yu, Yancheng,Yu, Quanwei,Liu, Simeng,Wu, Chenyang,Zhang, Xiaojin

, (2020/11/20)

Hypoxia-inducible factor-2 (HIF-2), a heterodimeric transcriptional protein consisting of HIF-2α and aryl hydrocarbon receptor nuclear translocator (ARNT) subunits, has a broad transcriptional profile that plays a vital role in human oxygen metabolism. M1001, a HIF-2 agonist identified by high-throughput screening (HTS), is capable of altering the conformation of Tyr281 of the HIF-2α PAS-B domain and enhancing the affinity of HIF-2α and ARNT for transcriptional activation. M1002, an analog of M1001, shows improved efficacy than M1001. However, the cocrystal structure of M1001 and HIF-2 has some defects in revealing the agonist binding mode due to the relatively low resolution, while the binding mode of M1002 remained unexplored. To in-depth understand agonist binding profiles, herein, the molecular dynamic (MD) simulations was applied to construct a stable agonist-protein model, and a possible binding mode was proposed through the analysis of the binding free energy and hydrogen bonding of the simulation results. Nine compounds were then synthesized and evaluated to verify the proposed binding mode. Among them, compound 10 manifested improved agonistic activity and reduced toxicity compared to M1002. This study provides deep insight into the binding mode of such HIF-2 agonists, which would be useful for designing novel agonists for HIF-2.

A Green One-Pot Synthesis of vic -Amidino (Hetero)aromatic Acids from 1,2-Dinitriles

Tkachuk, Volodymyr A.,Omelchenko, Iryna V.,Hordiyenko, Olga V.

supporting information, p. 851 - 857 (2017/04/06)

Phthalonitrile undergoes partial hydration in MeOH-H2O media in the presence of an equimolar amount of NaOH to afford 2-carbamimidoylbenzoic acid in good yield in one step. This and similar vic-amidino (hetero)aromatic acids also could be synthesized from corresponding 1,2-dinitriles by hydrolysis in aqueous MeOH catalyzed by an equimolar amount of NaOH of in situ generated 1,1-dimethoxy-1H-isoindol-3-amine or its counterparts. Protonation of the synthesized amidino acids, esterification, and reamination of the parent amidino benzoic acid with N-nucleophiles were performed.

Novel and mild route to phthalocyanines and 3-iminoisoindolin1-ones via N,N-diethylhydroxylamine-promoted conversion of phthalonitriles and a dramatic solvent-dependence of the reaction

Luzyanin, Konstantin V.,Kukushkin, Vadim Yu.,Kopylovich, Maximilian N.,Nazarov, Alexey A.,Galanski, Markus,Pombeiro, Armando J. L.

body text, p. 135 - 142 (2009/04/07)

Refluxing a mixture of phthalonitrile C6R1R 2R3R4(CN)2 1 (R1-R 4 = H), or its substituted derivatives 2 (R1, R 3, R4 = H, R2 = Me), or 3 (R1, R4 = H, R2, R3 = Cl) (lequiv.) and N,N-diethylhy-droxylamine, Et2NOH, (4 equivs.) in methanol for 4 h results (Route A) in precipitation of the symmetrical (6 and 8) and an isomeric mixture of unsymmetrical (7) phthalocyanines, isolated in good (55-65 % ) yields. The reaction of phthalonitriles 1, 2, or 4 (R1, R 3, R4 = H, R2 = NO2) (4 equivs.) with Et2NOH (8 equivs.) in the presence of a metal salt MCl 2 (M = Zn, Cd, Co, Ni) (1 equiv.) in n-BuOH or without solvent results in the formation of metallated phthalocyanine species (9-17). Upon refluxing in freshlydistilled dry chloroform, phthalonitrile 1 or its substituted analogues 2, 3 or 5 (R1-R4 = F) (1 equiv.) react with N,N-diethylhydroxylamine (2 equivs.) affording 3-iminoisoindolin-1- ones 18-21 (Route B) isolated in good yields (55-80%). All the prepared compounds were characterized with C, H, and N elemental analyses, ESI-MS, IR, and compounds 18-21 also by ID (1H, 13C(1H]), and 2D (1H,15N-HMBC and 1H,13CHMQC, 1H,13C-HMBC) NMR spectroscopy.

Structure, polymorphism and thermal properties of phenyliminoisoindolines

Zhang, Zhi-Qin,Uth, Samnang,Sandman, Daniel J.,Foxman, Bruce M.

, p. 769 - 776 (2007/10/03)

The crystal and molecular structures of (a) 1-imino-3-phenyliminoisoindoline (2), (b) two polymorphs (3Mono and 3Tric) and a nexane solvate (3Hex) of 1,3-bis(phenylimino)isoindoline (3) and (c) 3-phenyliminoisoindolinone (4) were determined via single-crystal x-ray diffraction. The two polymorphs and solvate of 3 were all obtained by crystallization from hexane. In the solid state, 2 is found as the anti isomer of the amino tautomer, and all forms of 3 exist as either the syn,anti or anti,anti isomers of the diimino tautomer. The 3Tric and 3Mono polymorphs represent a rare example in which the phenomena of conformational polymorphism and conformational isomorphism occur for the same substance. Compound 4 crystallizes as the anti isomer of the keto form. Differential scanning calorimetry and thermogravimetric analysis were performed to characterize the thermal properties of samples of 2-4. X-ray powder diffraction studies on 2, 3 and 4 reveal that, whereas specimens of 2 are a single phase, none of the samples of 3 and 4 crystallize as single phases under the conditions of the experiments. Copyright

Use of diiminoisoindoline derivatives or 3-aminoisoindolone derivatives for dyeing keratin fibers, and dye compositions containing them

-

, (2008/06/13)

Diiminoisoindoline derivatives or 3-aminoisoindolone derivatives, or tautomeric forms thereof, used as oxidizing-agent-free dye precursors in dyeing keratin fibers, in particular human keratin fibers such as the hair, without an oxidizing agent, in the presence of compounds containing a primary or secondary amine function; dye compositions containing these compounds and to the dyeing devices and processes used.

Novel Spirosuccinimides with Incorporated Isoindolone and Benzisothiazole 1,1-Dioxide Moieties as Aldose Reductase Inhibitors and Antihyperglycemic Agents

Wrobel, Jay,Dietrich, Arlene,Woolson, Shiela A.,Millen, Jane,McCaleb, Michael,et al.

, p. 4613 - 4627 (2007/10/02)

Compounds from two novel series of spirosuccinimides were prepared.Analogs of series 2 possessed a spiro-fused isoindolone moiety while those of series 3 contained a spiro-fused benzisothiazole S,S-dioxide group.These compounds were evaluated as aldose reductase inhibitors (ARI) in vitro by their ability to inhibit glyceraldehyde reduction using a partially purified bovine lens aldose reductase preparation and in vivo as inhibitors of galactitol accumulation in the lens, sciatic nerve, and diaphragm of galactose-fed rats.Many members from the isoindolone series 2,particularly those containing an isoindolone N-methyl moiety, showed good in vitro and in vivo potency.The most potent member, the 6-chloro analog 32, was resolved, and aldose reductase activity was found to reside almost exclusively in the (+)-enantiomer.Compound 32 was approximately equipotent in the sciatic nerve of the galactose-fed rat to other cyclic imide ARI's of similar in vitro activity, namely sorbinil and ADN-138 and also to tolrestat, an acetic acid-based ARI (ED50's 4-8 mg/kg).Compounds from both series, 2 and 3, were also found to lower plasma glucose levels of genetically obese db/db and ob/ob mice with potency similar to that of ciglitazone.However, members from these series failed to lower insulin levels of the ob/ob mouse at the doses tested.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 14352-51-3